Vireo Growth VREOF

OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 3:35 PM UTC
Financial Ratios
Market Cap11.86 Bn
P/E-238.00
P/S33.85
Div. Yield0.00
ROIC (Qtr)0.00
Total Debt (Qtr)198.60 Mn
Revenue Growth (1y) (Qtr)333.47
Add ratio to table…

About

Vireo Growth Inc. is a vertically integrated cannabis company operating in the United States cannabis industry. The company cultivates, manufactures, and distributes cannabis products through its license-holding subsidiaries in six states. Its operations include greenhouse and indoor cultivation facilities, extraction and processing laboratories, and retail dispensaries under brands such as Green Goods™ and other Vireo Growth branded stores. The company serves both medical…

Read more ↓
Sector: Consumer Staples Sector rationale Vireo Growth is a vertically integrated cannabis company that cultivates, manufactures, and retails cannabis products such as flower, oils, and edibles. According to the sector definitions, Cannabis is explicitly listed as an industry within the Consumer Staples sector. Industry: Cannabis Consumer Staples Primary Vireo Growth is a vertically integrated cannabis company that cultivates, manufactures, and sells cannabis products. Its revenue is derived from the sale of cannabis flower, oils, edibles, and vaporizer cartridges through its own dispensaries and third-party operators. Classified using BQ-MICS CIK: 0001771706

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 86.50 Bn80.681.67-5.81 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 42.71 Bn61.362.4716.59 Bn
3 ZTS Zoetis Inc. 30.86 Bn11.803.249.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 28.50 Bn49.630.6131.47 Bn
5 UTHR UNITED THERAPEUTICS Corp 22.06 Bn16.836.99-
6 VTRS Viatris Inc 18.84 Bn-45.871.2813.35 Bn
7 NBIX Neurocrine Biosciences Inc 15.55 Bn22.034.61-
8 VREOF Vireo Growth Inc. 11.86 Bn-238.0033.850.20 Bn